5,6-dimethyldibenzo[cd,f]indol-4(5H)-one | 1144526-50-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 菲及其衍生物
• 英文名称: 5,6-dimethyldibenzo[cd,f]indol-4(5H)-one
• 英文别名: 8,10-Dimethyl-10-azatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,4,6,8,12,14-heptaen-11-one
• CAS: 1144526-50-0
• 化学式: C₁₇H₁₃NO
• 分子量: 247.296
• InChiKey: OOGVRCOSBUXHTH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  19
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  4-溴-2-甲基异吲哚啉-1-酮 、 2-乙酰苯基硼酸 在 四(三苯基膦)钯 、 caesium carbonate 作用下， 以 乙醇 、 甲苯 为溶剂， 反应 0.17h， 以77%的产率得到5,6-dimethyldibenzo[cd,f]indol-4(5H)-one
  参考文献：
  名称：

  Synthesis of aristolactam analogues and evaluation of their antitumor activity

  摘要：

  A series of natural aristolactams and their analogues have been prepared and evaluated for antitumor activity against human cancer cells, including multi-drug resistant cell lines. Naturally occurring aristolactams, such as aristolactam BII (cepharanone B), aristolactam BIII, aristolactam FI (piperolactam A), N-methyl piperolactam A, and sauristolactam showed moderate antitumor activities in selected cell lines. However, several synthetic aristolactam derivatives exhibited potent antitumor activities against a broad array of cancer cell lines with GI(50) values in the submicromolar range. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.04.020

文献信息

• [EN] PHENANTHRENE LACTAM DERIVATIVES HAVING ANTICANCER ACTIVITY AND METHOD FOR THE PREPARATION THEREOF<br/>[FR] DÉRIVÉS DE LACTAME PHÉNANTHRÈNE PRÉSENTANT UNE ACTIVITÉ ANTICANCÉREUSE ET PROCÉDÉ DE PRÉPARATION DE CEUX-CI
  申请人：KOREA RES INST CHEM TECH

  公开号：WO2009051417A3

  公开（公告）日：2009-06-04
• Synthesis of aristolactam analogues and evaluation of their antitumor activity
  作者：Young Lok Choi、Joa Kyum Kim、Sang-Un Choi、Yong-Ki Min、Myung-Ae Bae、Bum Tae Kim、Jung-Nyoung Heo

  DOI：10.1016/j.bmcl.2009.04.020

  日期：2009.6

  A series of natural aristolactams and their analogues have been prepared and evaluated for antitumor activity against human cancer cells, including multi-drug resistant cell lines. Naturally occurring aristolactams, such as aristolactam BII (cepharanone B), aristolactam BIII, aristolactam FI (piperolactam A), N-methyl piperolactam A, and sauristolactam showed moderate antitumor activities in selected cell lines. However, several synthetic aristolactam derivatives exhibited potent antitumor activities against a broad array of cancer cell lines with GI(50) values in the submicromolar range. (C) 2009 Elsevier Ltd. All rights reserved.